Table 3.
Availability of medications by World Bank income level of respondent countries
| Availability according to manufacturer (n) | Respondents' awareness of medication availability % (n/base) | |||||
|---|---|---|---|---|---|---|
| Medication | All (n = 121) | High (n = 36) | UM (n = 36) | LM (n = 30) | Low (n = 19) | All |
| NRT | 51 (62) | 97 (35) | 61 (22) | 17 (5) | 0 (0) | 92 (57/62) |
| Bupropion | 17 (20) | 42 (15) | 14 (5) | 0 (0) | 0 (0) | 100 (20/20) |
| Varenicline | 52 (63) | 83 (30) | 58 (21) | 33 (10) | 11 (2) | 86 (54/63) |
| Cytisine | 10 (12) | 3 (1) | 17 (6) | 13 (4) | 5 (1) | 67 (8/12) |
LM = lower-middle-income; NRT = nicotine replacement therapy; UM = upper-middle-income. The bases used in the final column were the ‘n’ values given for the respective medications in the second column.